14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 INDP stock ended at $2.02. This is 0.748% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.79% from a day low at $2.01 to a day high of $2.11.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Indaptus Therapeutics, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $2.11 $2.11 $2.01 $2.02 2 752
May 02, 2024 $2.00 $2.16 $1.98 $2.01 11 044
May 01, 2024 $2.26 $2.28 $2.00 $2.03 20 322
Apr 30, 2024 $2.14 $2.23 $2.14 $2.17 4 759
Apr 29, 2024 $2.25 $2.25 $2.06 $2.12 7 624
Apr 26, 2024 $2.22 $2.22 $2.05 $2.11 8 071
Apr 25, 2024 $2.31 $2.31 $2.18 $2.18 29 120
Apr 24, 2024 $2.45 $2.67 $2.26 $2.35 49 591
Apr 23, 2024 $2.68 $2.68 $2.47 $2.49 7 359
Apr 22, 2024 $2.39 $2.47 $2.39 $2.44 4 130
Apr 19, 2024 $2.49 $2.56 $2.35 $2.36 10 527
Apr 18, 2024 $2.58 $2.63 $2.45 $2.52 26 969
Apr 17, 2024 $2.74 $2.74 $2.35 $2.66 25 058
Apr 16, 2024 $2.69 $2.79 $2.69 $2.79 7 262
Apr 15, 2024 $2.95 $2.95 $2.52 $2.62 54 903
Apr 12, 2024 $2.74 $2.87 $2.72 $2.77 53 830
Apr 11, 2024 $2.54 $2.75 $2.45 $2.75 92 466
Apr 10, 2024 $2.48 $2.54 $2.31 $2.52 20 098
Apr 09, 2024 $2.44 $2.46 $2.32 $2.46 10 267
Apr 08, 2024 $2.47 $2.47 $2.31 $2.39 13 228
Apr 05, 2024 $2.25 $2.48 $2.25 $2.44 23 003
Apr 04, 2024 $2.20 $2.29 $2.09 $2.25 9 020
Apr 03, 2024 $2.27 $2.30 $2.25 $2.25 10 466
Apr 02, 2024 $2.33 $2.34 $2.26 $2.34 6 743
Apr 01, 2024 $2.36 $2.52 $2.30 $2.30 29 477
Click to get the best stock tips daily for free!

About Indaptus Therapeutics, Inc.

Indaptus Therapeutics. Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was fo... INDP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT